BRIEF-Thrombogenics says to explore strategic options for the company

BRUSSELS Mon Feb 24, 2014 1:35am EST

Related Topics

BRUSSELS Feb 24 (Reuters) - ThromboGenics NV : * To explore strategic options for the company * Decision to increase the company's ability to realize the significant commercial potential of jetrea in the US * Thr.br-says the board has retained Morgan Stanley to help with the strategic review process

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.